[Federal Register Volume 68, Number 126 (Tuesday, July 1, 2003)]
[Notices]
[Pages 39093-39098]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-16530]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Program Announcement 03090]


Technology Translation and Transfer of Effective HIV Prevention 
Behavioral Interventions; Notice of Availability of Funds

    Application Deadline: July 31, 2003.

A. Authority and Catalog of Federal Domestic Assistance Number

    This program is authorized under section 301 and 317(k) of the 
Public Health Service Act, (42 U.S.C. section 241 and 247b(k)), as 
amended. The Catalog of Federal Domestic Assistance number is 93.941.

B. Purpose

    The Centers for Disease Control and Prevention (CDC) announces the 
availability of fiscal year (FY) 2003 funds for a cooperative agreement 
program for the Technology Translation and Transfer of Effective HIV 
Prevention Behavioral Interventions. This program addresses the 
``Healthy People 2010'' focus area of HIV.
    The purpose of the program is to: (1) Support translation of the 
protocols for effective HIV prevention interventions, in which the 
original research was conducted with methodological rigor and which 
have not been packaged or widely adopted, into a package of materials 
that state, local, and non-profit prevention providers can use to 
implement the interventions in their non-research field situations; and 
(2) Support development of curricula for training provider agency staff 
who will implement the intervention on how to deliver the packaged 
intervention with fidelity and on technical skills needed to conduct 
the intervention, and technical assistance guidance manuals for 
providing technical assistance to future adopters of the intervention.
    Measurable outcomes of the program will be in alignment with one or 
more of the following performance goals for the National Center for 
HIV, STD, and TB Prevention (NCHSTP): Strengthen the capacity 
nationwide to monitor the epidemic, develop and implement effective HIV 
prevention interventions and evaluate prevention programs and to also 
decrease the number of persons at high risk for acquiring or 
transmitting HIV infection.

C. Eligible Applicants

    Applications may be submitted by non-profits organizations and by 
governments and their agencies in the United States; that is: public 
nonprofit organizations; private nonprofit organizations; for profit 
organizations; universities; colleges; research institutions; 
hospitals; community-based organizations; state and local governments 
or their bona fide agents (this includes the District of Columbia, the 
Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of 
the Northern Marianna Islands, American Samoa, Guam, the Federated 
States of Micronesia, the Republic of the Marshall Islands, and the 
Republic of Palau); political subdivisions of States (in consultation 
with States); small, minority, women owned businesses; technical 
schools; faith-based organizations; and federally recognized Indian 
tribal governments. If any of the aforementioned organizations,

[[Page 39094]]

institutions, universities, research hospitals, etc., do not have the 
following qualifications they will not be eligible to apply for this 
program: (1) Researchers who have developed proven HIV behavioral 
prevention interventions; (2) persons with experience using protocols 
to conduct HIV behavioral interventions; or (3) persons with expertise 
in curricula and package development. If agencies are interested in 
applying for funding under this announcement but are not of a group 
listed as eligible, they are encouraged to partner with an eligible 
entity, combine their capacities, and submit a joint application. The 
eligible partner must be the lead applicant and must conduct at least 
50 percent of the program's activities.

    Note: Title 2 of the United States Code section 1611 states that 
an organization described in section 501(c)(4) of the Internal 
Revenue Code that engages in lobbying activities is not eligible to 
receive Federal funds constituting an award, grant or loan.

D. Funding

Availability of Funds

    Approximately $470,000 is available in FY 2003 to fund 
approximately two awards. It is expected that the average award will be 
$215,000, ranging from $200,000 to $235,000. It is expected that the 
awards will begin on or about September 15, 2003, and will be made for 
a 12-month budget period within a project period of up to two years. 
Funding estimates may change.
    Continuation awards within an approved project period will be made 
on the basis of satisfactory progress, as evidenced by required reports 
and the availability of funds. Continued funding for year two will be 
dependent on the completion of required activities for year one.

Use of Funds

    Collection of new or supplemental intervention research outcomes 
data, data entry and analysis, other than for process evaluation of 
this project, purchase of furniture or computers, and rental of 
facilities will not be funded under this program.

Recipient Financial Participation

    Matching funds are not required for this program.

Funding Priority

    CDC's intention is to support the packaging of interventions for 
target populations not currently represented in the Replicating 
Effective Programs collection of packages. This announcement is only 
for proposals that submit an HIV prevention intervention with 
demonstrated effectiveness in changing HIV/STD-related risk behavior or 
health outcomes. Consideration will be given to obtaining diversity of 
at-risk populations among the proposals selected for funding. 
Interventions are sought for any population at risk of acquiring or 
transmitting HIV; however, the following populations are of particular 
interest: (1) Persons with HIV infection; (2) African American men 
having sex with men (MSM); (3) Hispanic MSM; (4) incarcerated persons; 
(5) sex workers, (6) transgender persons; and (7) persons living in 
rural areas whose behaviors put them at risk for HIV infection.

E. Program Requirements

    In conducting activities to achieve the purpose of this program, 
the recipient will be responsible for the activities listed in 1. 
Recipient Activities, and CDC will be responsible for the activities 
listed in 2. CDC Activities.

1. Recipient Activities

    The program requirements for the first year of activity include:
    a. Develop the intervention package, including promotional or 
marketing material for program administrators, and preliminary versions 
of the training curricula in collaboration with HIV prevention 
providers and consumers.
    b. Produce enough intervention packages so that each case study 
agency can receive one for each staff member delivering the 
intervention, the researcher's team has at least one package; and the 
CDC Project Officer has one package. The number of packages will depend 
upon the structure of the intervention, how many case study agencies 
test the package, and how many facilitators there are at each agency.
    c. Identify at least two HIV prevention agencies, which are not 
collaborating on package development, for case study of the technology 
transfer process.
    d. Develop a plan to evaluate the implementation process.
    Program requirements for the second year of activity include:
    a. Initiate the prevention agency case study using the intervention 
package, training curricula, quality assurance, and technical 
assistance.
    b. Complete the case study by achieving technology transfer with at 
least one of the selected agencies.
    c. Initiate and complete the implementation process evaluation.
    d. Revise intervention and training materials based upon the case 
study results.
    e. Develop technical assistance guidance manuals based on transfer 
experience.
    f. Publish and distribute results.

2. CDC Activities

    a. Host a meeting with the successful applicants within 60 days of 
the notice of award to discuss implementation of the project. CDC will 
host two meetings per project year to facilitate the sharing of 
experiences and lessons learned by the recipients of this funding and 
the recipients of Replicating Effective Programs (REP) funding under 
other announcements.
    b. Provide technical assistance in the general operation of this 
HIV prevention project, including but not limited to detailed advice on 
steps to accomplish the recipient activities, composition of community 
advisory boards, cost containment strategies for video production, 
package production issues (e.g., reading level, format, layout), topics 
to include in Memoranda of Agreement with case study agencies, 
strategies for collecting process measures and tracking implementation 
costs, and responses to recipient questions and requests.
    c. Consult on the choice of prevention agencies for the case 
studies with the intervention package by suggesting selection criteria, 
assisting in identifying potential agencies in the event that a 
recipient has difficulty, and approving the final choices.
    d. Monitor and evaluate scientific and operational accomplishments 
of this project through frequent telephone contact and review of 
technical reports, package iterations, and interim data analyses. 
Project Officers will conduct monthly calls with individual recipients 
and monthly conference calls with all current recipients of REP 
funding, will read and edit iterations of the package and video 
scripts, and will make recommendations aimed at solving problems and 
improving the quality and timeliness of recipient activities.
    e. Conduct at least one site visit per year to assess program 
progress and mutually solve problems, and additional visits as needed.

F. Content

Applications

    The Program Announcement title and number must appear in the 
application. Use the information in the Program Requirements, Other 
Requirements, and Evaluation Criteria sections to develop the 
application content. Your application will be evaluated on the criteria 
listed, so it is important to follow them in laying out your program

[[Page 39095]]

plan. The narrative should be no more than 20 pages, double-spaced, 
printed on one side, with one-inch margins, and unreduced 12-point 
font.
    The narrative should consist of a one-page abstract of the 
proposal, a complete table of contents to the application and its 
appendices, and text addressing each required element. Beginning with 
the first page of text, number all pages clearly and sequentially, 
including each page in the appendices. Replace double-sided article 
reprints with a one-sided copy.
    Include a general introduction, followed by one narrative 
subsection for each of the numbered content elements per application, 
in the order in which the elements appear below. Label each narrative 
subsection with the element title and include all of the information 
needed to evaluate that element of the application (except for 
curriculum vitae, references, line item budget justification, and 
letters of support, which are appropriate for the appendices). The 
application's narrative content elements are:
1. Capacity, and the Degree to Which the Applicant Has Met the CDC 
Policy Requirements Regarding the Inclusion of Women, Ethnic, and 
Racial Groups in the Proposed Research
    a. Demonstrate capacity to conduct the activities required for this 
project.
    b. Clearly describe the proposed staffing, e.g., show percentages 
of each staff member's commitment to this and other projects, the 
division of duties and responsibilities for this project, brief 
position descriptions for existing and proposed personnel, and any 
partnerships with HIV prevention agencies.
    c. Demonstrate that the applicant's staff has the expertise to 
complete this project, including ability to produce the intervention 
package, e.g., include examples of previously developed fact sheets, 
CD-ROMs, web sites, or samples from other intervention packages.
    d. Name the staff members who are key to the completion of the 
project. Provide a brief description of their strengths that relate to 
this project. Include their curriculum vitae in the appendix.
    e. Describe access to graphics expertise for the editing and 
production of the intervention package in print and/or electronic 
formats.
    f. Briefly describe compliance regarding the inclusion of women, 
ethnic, and racial groups in the proposed activities or justification 
when representation is limited or absent.
2. Effective Behavioral Intervention
    a. Identify the principal investigator (PI); name and location of 
the institution(s) that originally developed, conducted, and evaluated 
the proposed intervention; and population(s) for whom the intervention 
was designed. Indicate whether the research was part of a multi-site 
project.
    b. If the research was part of a multi-site project with a common 
protocol, provide letters of support from original developers of the 
intervention other than the applicant (e.g., PIs at other sites) 
indicating their intent to collaborate on a portion of the intervention 
materials that will discuss generalizing the intervention to other 
target populations or settings.
    c. Where the applicant is not an original developer of the 
intervention, provide written permission from the intervention's 
original developers to develop and market materials for the 
intervention package.
    d. Describe the research's results on behavioral or health 
outcomes, including how these results are both statistically and 
practically significant; and, if the intervention is community-level, 
how long the intervention was in operation before positive effects were 
detected.
    e. Include in the appendix a copy of any reports, which have been 
submitted to the institution funding the research, have been submitted 
for publication, or have been published in peer reviewed journals, 
describing the study design and positive behavioral or health outcomes 
of the intervention. This portion of the appendix should be labeled as 
``Intervention Study Design and Results.''
    f. Substantiate the need for an intervention package in terms of 
the target population's risk and the intervention's potential for being 
generalized to other populations at risk for HIV infection.
    g. Describe the feasibility of implementation by HIV prevention 
agencies, particularly those with limited resources, and the number of 
at-risk persons an agency could potentially reach with the intervention 
annually.
3. Plan for Intervention Package Development
    a. Describe the contents of the intervention package that will be 
developed. Include descriptions of: (1) The overall concept, format, 
and objectives to be in text and in short promotional or marketing 
materials for program administrators, e.g., appropriateness for 
intended implementing agencies, description of the intervention and the 
science behind it, target populations for whom the intervention would 
be appropriate; (2) The intervention's pre-implementation phase, e.g., 
intervention's core elements related to this phase, time line of 
necessary preparation steps, list of collaborators, training materials, 
material resources, facilities, staff (numbers, time commitment, and 
skills), and cost categories for conducting the intervention; (3) The 
intervention's implementation phase, e.g., intervention's core elements 
related to this phase, protocols and examples for implementing the 
intervention and ensuring quality and consistency, identification of 
barriers to implementation and advice on how they may be overcome, and 
methods for process evaluation; and (4) The intervention's maintenance 
phase, e.g., intervention's core elements related to this phase, how to 
deal with issues of staff turnover and retraining.
    b. Explain how staff from HIV prevention programs (e.g., health 
departments and community-based organizations) and/or other prevention 
providers and consumers in the applicant's geographic area will 
collaborate in the development of the intervention package. Describe 
the planned procedures for how these collaborators will be identified.
    c. Present a time line for developing and reviewing the 
intervention package and its components.
4. Plan To Identify Prevention Agencies for Case Study of Implementing 
the Packaged Intervention in Year Two
    a. Discuss a plan to identify and recruit potential implementers 
within your state or nearby (i.e., where training, assistance, and 
evaluation will be feasible within budget constraints) and indicate any 
agencies that have already shown interest in or may be interested in 
implementing the proposed intervention.
    b. Elaborate on the criteria and mechanism for selecting agencies 
that will participate in case studies of implementing the packaged 
intervention.

    Note: Any agency that participated in the intervention's 
original research is excluded from consideration as a potential 
implementer, as is any agency that currently or previously 
implemented the intervention.

5. Methods To Assist Implementation
    a. Describe the strategy to facilitate implementation of the 
packaged intervention, including development of training curricula, 
provision of training, and provision of direct technical assistance 
from the applicant to the

[[Page 39096]]

selected case study agencies. Describe plans for assisting selected 
users find additional funds, if it becomes necessary.
    b. Discuss procedures to assist selected agencies to implement the 
packaged intervention, drawing upon the agencies' existing staff and 
resources, and to identify barriers to implementation and how to 
overcome them.
6. Evaluation of the Implementation Process
    a. Describe methods and measures to be used in assessing: (1) 
Fidelity to the intervention's core elements during the implementation 
phases as specified in the intervention package; (2) quality of 
intervention delivery according to the methods described in the 
package; (3) quality of the applicant's technical assistance and its 
delivery; (4) impact of barriers to implementation on the case study 
(e.g., accuracy of record keeping, agency's staff recruitment and 
training, client recruitment); (5) effectiveness of solutions to 
barriers; (6) costs of intervention delivery and cost containment 
strategies; and (7) maintenance of collaborative relationships. No 
behavioral or health outcomes are to be evaluated.
    b. Describe plan to use the process evaluation results in 
finalizing the intervention package and the training curricula for 
agency staff and for the preparation of guidance manuals for future 
technical assistance providers.

    Note: The purpose of the program includes achieving technology 
transfer with at least one HIV prevention agency and studying the 
process. Selection of two or more implementing agencies may increase 
the likelihood of achieving technology transfer (i.e., entering 
implementation phase and conducting all intervention components) 
with at least one agency.

7. Budget
    Provide a detailed, line-item budget for the project; justify each 
line item. Plan for two trips to Atlanta each year to meet with CDC 
representatives. Any application requesting greater than $235,000 
(including indirect costs) will not be considered for review and will 
be returned to the applicant.
8. Performance Goals
    Describe how the measurable outcomes of the program will be in 
alignment with one or more of the following performance goals:
    a. Strengthen the capacity nationwide to monitor the epidemic, 
develop and implement effective HIV prevention interventions and 
evaluate prevention programs.
    b. Decrease the number of persons at high risk for acquiring or 
transmitting HIV infection.

G. Submission and Deadline

Application Forms

    Submit the signed original and two copies of PHS 5161-1 (OMB number 
0920-0428). Forms are available at the following Internet address: 
http://www.cdc.gov/od/pgo/forminfo.htm.
    If you do not have access to the Internet, or if you have 
difficulty accessing the forms on-line, you may contact the CDC 
Procurement and Grants Office Technical Information Management Section 
(PGO-TIM) at: 770-488-2700. Application forms can be mailed to you.

Submission Date, Time, and Address

    The application must be received by 4 p.m. Eastern Time July 31, 
2003. Submit the application to: Technical Information Management-
PA 03090, CDC Procurement and Grants Office, 2920 Brandywine 
Road, Atlanta, GA 30341-4146.
    Applications may not be submitted electronically.

CDC Acknowledgement of Application Receipt

    A postcard will be mailed by PGO-TIM, notifying you that CDC has 
received your application.

Deadline

    Applications shall be considered as meeting the deadline if they 
are received before 4 p.m. Eastern Time on the deadline date. Any 
applicant who sends their application by the United States Postal 
Service or commercial delivery services must ensure that the carrier 
will be able to guarantee delivery of the application by the closing 
date and time. If an application is received after closing due to (1) 
carrier error, when the carrier accepted the package with a guarantee 
for delivery by the closing date and time, or (2) significant weather 
delays or natural disasters, CDC will, upon receipt of proper 
documentation, consider the application as having been received by the 
deadline.
    Any application that does not meet the above criteria will not be 
eligible for competition, and will be discarded. The applicant will be 
notified of their failure to meet the submission requirements.

H. Evaluation Criteria

Application

    Applicants are required to provide measures of effectiveness that 
will demonstrate the accomplishment of the various identified 
objectives of the cooperative agreement. Measures of effectiveness must 
relate to the performance goals stated in the purpose section of this 
announcement. Measures must be objective and quantitative and must 
measure the intended outcome. These measures of effectiveness must be 
submitted with the application and will be an element of evaluation.
    An independent review group appointed by CDC will evaluate each 
application against the following criteria:
    1. Demonstrated Capacity and the degree to which the applicant has 
met the CDC Policy requirements regarding the inclusion of women, 
ethnic, and racial groups in the proposed research (25 points) a. 
Demonstrated Capacity. Overall ability of the applicant to perform the 
proposed activities as reflected in their staff's and consultants' 
qualifications and availability. The extent to which the applicant 
demonstrates that proposed staff have experience with developing 
materials in various formats, training, and process evaluation and have 
demonstrated familiarity with HIV behavioral interventions, 
particularly the intervention to be packaged. The nature of any 
partnership between researchers and HIV prevention programs. Adequacy 
of existing support staff, equipment, and facilities.
    b. The degree to which the applicant has met the CDC Policy 
requirements regarding the inclusion of women, ethnic, and racial 
groups in the proposed research. This includes: (1) The proposed plan 
for the inclusion of both sexes and racial and ethnic minority 
populations for appropriate representation; (2) The proposed 
justification when representation is limited or absent; (3) A statement 
as to whether the design of the study is adequate to measure 
differences when warranted; (4) A statement as to whether the plans for 
recruitment and outreach for study participants include the process of 
establishing partnerships with community(ies) and recognition of mutual 
benefits.
    2. Effective Behavioral Intervention (20 points). Clear 
demonstration of the effectiveness of the proposed intervention in a 
report that has been: (1) Submitted to the institution funding the 
research; (2) submitted for publication, or published in a peer-
reviewed journal. This is an absolute criterion.
    To be considered effective, the intervention must have: (1) Tested 
using a control or comparison group with participants assigned randomly 
or without bias to study conditions; (2) measured using pre- and post-

[[Page 39097]]

intervention outcomes; (3) retained at least 70 percent of the study 
participants; (4) completed the data collection and analyses; and (5) 
results that show significant positive findings (and no significant 
negative results) for changing HIV/STD-related risk behavior or health 
outcomes. If this evidence is present, also consider:
    a. The original research for this intervention was conducted and 
completed with a population at demonstrable risk for acquiring or 
transmitting HIV, preferably persons with HIV infection, African 
American men having sex with men (MSM), Hispanic MSM, incarcerated 
persons, sex workers, transgender persons, or persons living in rural 
areas whose behaviors put them at risk for HIV infection.
    b. The feasibility of implementing the proposed intervention by 
agencies with limited resources and the number of at-risk persons an 
agency could reach.
    c. Letters of permission from the intervention's developer(s) to 
develop and market materials for the proposed intervention package and, 
if the intervention was from a multi-site project with a common 
protocol, letters of participation from the same developers.
    3. Plan for Intervention Package Development (15 points). Level of 
detail in the outline of the proposed package, e.g., for overview, pre-
implementation, implementation, and maintenance phases. Clarity of 
described formats, concepts, intended implementers, and objectives. 
Justification of the appropriateness of the package's objectives, 
format and concepts to the intended implementing agencies' needs and 
capabilities. Adequacy of planned identification, of and input from, 
collaborating HIV prevention programs and/or other prevention providers 
and consumers. Adequacy of planned materials' review, pre-testing, and 
revision. Adequacy of time scheduled for completing the proposed steps 
of the package's development and contents.
    4. Plan to Identify Prevention Agencies to Implement the Packaged 
Intervention (15 points). Recognition of which agencies are not 
eligible to participate in the implementation case study. Quality of 
plan to identify eligible potential agencies with at-risk populations 
for whom the intervention is appropriate and to interest them in 
implementing the package during year two of the project. Selection of 
active methods to identify and solicit potential implementing agencies. 
Adequacy of criteria and mechanism for selecting at least two 
implementing agencies likely to achieve technology transfer.
    5. Methods to Assist Implementation (15 points). Clarity of the 
strategy to assist selected agencies in adopting and implementing the 
proposed intervention, e.g., outline of training curricula and training 
plan. Understanding of barriers to implementation and how to overcome 
them. Plan to assist selected users in implementing the entire 
intervention using their existing resources and staff, e.g., provision 
of proactive and on-call technical assistance. Plan to help selected 
agencies find additional funds for implementing the package in year 
two, if relevant.
    6. Evaluation of Implementation Process (10 points). Feasibility 
and appropriateness of the applicant's plan to evaluate the selected 
agencies' implementation of the intervention as specified in the 
intervention package. Thorough and realistic selection of process 
measures to evaluate. Adequacy of plans for revising intervention 
package and training materials based upon the case study results. 
Adequacy of plans for developing a technical assistance manual based on 
the agencies' and applicant's implementation and transfer experiences.
    7. Budget (Reviewed, but not scored). Extent to which the budget is 
reasonable, itemized, clearly justified, and consistent with the 
intended use of the funds. Extent to which the budget includes 
itemizations, justifications, scope, and deliverables for consultants 
or contractors.
    8. Performance goals (Reviewed, but not scored). Extent to which 
the program's proposed measures will demonstrate effective 
accomplishment of the purposes and one or more performance goals of the 
cooperative agreement.
    Does the application adequately address the requirements of Title 
45 CFR Part 46 for the protection of human subjects? Not scored; 
however, an application can be disapproved if the research risks are 
sufficiently serious and protection against risks is so inadequate as 
to make the entire application unacceptable.

I. Other Requirements

Technical Reporting Requirements

    Provide CDC with an original, plus two copies of:
    1. Interim progress report, no less than 90 days before the end of 
the budget period. The progress report will serve as your non-competing 
continuation application, and must contain the following elements:
    a. Current Budget Period Activities Objectives.
    b. Current Budget Period Financial Progress.
    c. New Budget Period Program Proposed Activity Objectives.
    d. Detailed Line-Item Budget and Justification.
    e. Additional Requested Information.
    2. Financial status report, no more than 90 days after the end of 
the budget period.
    3. Final financial and performance reports, no more than 90 days 
after the end of the project period.
    Send all reports to the Grants Management Specialist identified in 
the ``Where to Obtain Additional Information'' section of this 
announcement.
    At the completion of two years of funding, recipients will be 
expected to share print, and possibly electronic, copies of the revised 
intervention packages with representatives of the agencies that 
implemented the intervention for the program's case studies, with CDC 
project officers, and with the intervention's developers, if different 
from the applicant.

Additional Requirements

    The following additional requirements are applicable to this 
program. For a complete description of each, see Attachment I of the 
program announcement, as posted on the CDC web site.

AR-1 Human Subjects Requirements
AR-2 Requirements for Inclusion of Women and Racial and Ethnic 
Minorities in Research
AR-4 HIV/AIDS Confidentiality Provisions
AR-5 HIV Program Review Panel Requirements
AR-7 Executive Order 12372 Review
AR-8 Public Health System Reporting Requirements
AR-9 Paperwork Reduction Act Requirements
AR-10 Smoke-Free Workplace Requirements
AR-11 Healthy People 2010
AR-12 Lobbying Restrictions
AR-14 Accounting System Requirements
AR-15 Proof of Non-Profit Status

J. Where To Obtain Additional Information

    This and other CDC announcements, the necessary applications, and 
associated forms can be found on the CDC web site, Internet address: 
http://www.cdc.gov. Click on ``Funding'' then ``Grants and Cooperative 
Agreements''.
    For general questions about this announcement, contact: Technical

[[Page 39098]]

Information Management, CDC Procurement and Grants Office, 2920 
Brandywine Road, Atlanta, GA 30341-4146, Telephone: 770-488-2700.
    For business management and budget assistance, contact: Vincent 
Falzone, Grants Management Specialist, Procurement and Grants Office, 
Centers for Disease Control and Prevention, 2920 Brandywine Road, 
Atlanta, GA 30341-4146, Telephone: 770-488-2700.
    For program technical assistance, contact: Craig Studer, Deputy 
Branch Chief, Division of HIV/AIDS Prevention, National Center for HIV/
STD/TB Prevention, Centers for Disease Control and Prevention, 1600 
Clifton Road, NE, Mailstop E-37, Atlanta, GA 30333, Telephone: 404-639-
5389, E-mail address: [email protected].

    Dated: June 25, 2003.
Sandra R. Manning,
Director, Procurement and Grants Office, Centers for Disease Control 
and Prevention.
[FR Doc. 03-16530 Filed 6-30-03; 8:45 am]
BILLING CODE 4163-18-P